Alkermes plc (ALKS) Financials

ALKS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 4.4 billion 2.6 billion
March 31, 2026 4.3 billion 2.5 billion
Dec. 31, 2025 2.5 billion 711.0 million
Sept. 30, 2025 2.3 billion 596.1 million

ALKS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 137.0 million 31.1 million
March 31, 2026 -169.8 million 36.3 million
Dec. 31, 2025 170.1 million -72.4 million
Sept. 30, 2025 84.4 million 24.7 million

ALKS Net Income

No data available :(

ALKS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 656.6 million 1.5 billion 69.5 million
March 31, 2026 511.9 million 1.5 billion 71.3 million
Dec. 31, 2025 1.3 billion - 63.3 million
Sept. 30, 2025 1.1 billion - 71.6 million

ALKS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 166.6 million
March 31, 2026 166.2 million
Dec. 31, 2025 168.7 million
Sept. 30, 2025 168.5 million

ALKS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 8.1 million 112.9 million 217.6 million 154.3 million
March 31, 2026 4.1 million 103.3 million 264.6 million 155.6 million
Dec. 31, 2025 20000 93.0 million 190.5 million 89.7 million
Sept. 30, 2025 17.3 million 81.7 million 171.8 million 115.6 million

ALKS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 496.0 million 98.1 million
March 31, 2026 392.9 million 61.6 million
Dec. 31, 2025 384.5 million 46.2 million
Sept. 30, 2025 394.2 million 51.6 million

ALKS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ALKS

Price: $46.10

52 week price:
25.17
55.67

Payout Ratio Range:
-28.47%
29.06%

Earnings Per Share: 0.38 USD

P/E Ratio: 130.34

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Ireland

Volume: 283127

Ebitda: 39.2 million

Market Capitalization: 8.3 billion

Links: